Chitosan-sodium lauryl sulfate nanoparticles as a carrier system for the in vivo delivery of oral insulin

AAPS PharmSciTech. 2011 Sep;12(3):958-64. doi: 10.1208/s12249-011-9647-5. Epub 2011 Jul 15.

Abstract

The present work explores the possibility of formulating an oral insulin delivery system using nanoparticulate complexes made from the interaction between biodegradable, natural polymer called chitosan and anionic surfactant called sodium lauryl sulfate (SLS). The interaction between chitosan and SLS was confirmed by Fourier transform infrared spectroscopy. The nanoparticles were prepared by simple gelation method under aqueous-based conditions. The nanoparticles were stable in simulated gastric fluids and could protect the encapsulated insulin from the GIT enzymes. Additionally, the in vivo results clearly indicated that the insulin-loaded nanoparticles could effectively reduce the blood glucose level in a diabetic rat model. However, additional formulation modifications are required to improve insulin oral bioavailability.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Administration, Oral
  • Animals
  • Biological Availability
  • Blood Glucose / drug effects
  • Chitosan / administration & dosage
  • Chitosan / chemistry*
  • Diabetes Mellitus, Experimental / therapy*
  • Drug Delivery Systems / methods
  • Insulin / administration & dosage
  • Insulin / chemistry*
  • Insulin / pharmacokinetics*
  • Insulin / therapeutic use
  • Male
  • Nanoparticles / administration & dosage
  • Nanoparticles / chemistry*
  • Nanoparticles / ultrastructure
  • Particle Size
  • Rats
  • Rats, Wistar
  • Sodium Dodecyl Sulfate / administration & dosage
  • Sodium Dodecyl Sulfate / chemistry*
  • Spectroscopy, Fourier Transform Infrared
  • Technology, Pharmaceutical / methods

Substances

  • Blood Glucose
  • Insulin
  • Sodium Dodecyl Sulfate
  • Chitosan